All timeline stories.
Similar to the Aristat timeline, the vaccine transporter should be launched by 2027. ….and further research Once commercial plans have been put in motion and successful. Further funds shall be put in research to develop new cooling inventions.
The vaccine transporter will undergo a series of qualification tests such as WHO and ASTS standards.
Additional efforts will be dedicated to further developing the vaccine transporter, aiming to attract additional investment specifically targeted towards this project.
The next phase involves establishing the project as an independent commercial company, focused on securing commercial investment and generating revenue streams as outlined in the business plan. Negotiations are ongoing to identify products for licensing or direct sale to consumers. The core team will also be established.
A first batch of 10 Controllers was produced and distributed amongst first users for bug tracking and feedback. This version also includes a polished GUI interface, which allows for flexible operation, as well as monetisation of the algorithm. A website update was also prepared for pre-orders
The team successfully applied for MCST’s GoTo Market funding programme, named GLACIER, securing another €100,000 in funding for the next 1.5 years. This investment enabled them to pursue further IP protection, and push for core platform, and vaccine transporter to be commercialised.
ICECAP’s technology was successfully integrated within MEMENTO’s High speed imaging system. This included validated power supplies, several isolation systems (including vacuum chambers), and custom heat dissipation methods.
Starting Q1, a vaccine transporter demonstrator was developed, reaching TRL3 and demonstrating electrical and UI functionality, including the frontend GUI and IOT tracking. Read more
Method and system for power optimization for system of thermoelectric cooling devices – WO2024018287A1 Multilevel thermoelectric cooling stack with thermal guard rings – WO2024018288A1